- ►diabetesjournals.org PJ Larsen, PB Jensen, RV Sørensen, LK … - Diabetes, 2003 - Am Diabetes Assoc Chronic treatment with compounds activating peroxisome proliferator–activated
receptor (PPAR)γ and -α influences body energy stores, but the underlying
mechanisms are only partially known. In a chronic-dosing study, ... Cited by 64 - Related articles - BL Direct - All 4 versions
HJ Lee, SS Choi, MK Park, YJ An, SY Seo, … - Biochemical and biophysical research communications, 2002 - Elsevier The effect of peroxisome proliferator-activated receptor (PPAR)-α activators on
the liver is well established, but the other effects on muscle and adipose
tissue about lipid metabolism and insulin sensitivity are not clear. We ... Cited by 78 - Related articles - BL Direct - All 6 versions
FP Mancini, A Lanni, L Sabatino, M Moreno, A … - FEBS letters, 2001 - Elsevier Fibrates are hypolipidemic drugs that activate the peroxisome
proliferator-activated receptors. Since fibrates may also increase energy
expenditure, we investigated whether fenofibrate (FF) had this effect in ... Cited by 70 - Related articles - All 6 versions
E Chaput, R Saladin, M Silvestre, AD Edgar - Biochemical and Biophysical Research …, 2000 - Elsevier Activators of peroxisome proliferator activated receptors (PPARs) are effective
drugs to improve the metabolic abnormalities linking hypertriglyceridemia to
diabetes, hyperglycemia, insulin-resistance, and atherosclerosis. We ... Cited by 133 - Related articles - BL Direct - All 6 versions
AMCP Joosen, AHF Bakker, MJA Gering, KR … - Diabetes/Metabolism Reviews - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 11 - Related articles - BL Direct - All 3 versions
K YAMAMOTO, N FUKUDA, LEI ZHANG, T … - Pharmacological research, 1996 - Elsevier The aim of this study was to examine the effects of dietary fenofibrate (0.05%
in the diet) on ketone body production and lipid secretion in isolated perfused
rat liver. Feeding with fenofibrate for 7–9 days caused an increased ... Cited by 15 - Related articles - BL Direct - All 5 versions
F Rizvi, A Puri, G Bhatia, AK Khanna, EM … - Biochemical and Biophysical Research …, 2003 - Elsevier Fenofibrate is the ligand for PPARα subtype that mediates the action of its
agonists' in lipid metabolism. How fibrate exerts hypolipidemic effect? The
mechanism is studied in a newly developed high-fat fructose enriched diet ... Cited by 16 - Related articles - BL Direct - All 4 versions
LC Pickavance, CL Brand, K Wassermann, … - British journal of pharmacology, 2005 - pubmedcentral.nih.gov Insulin sensitivity was improved equally by RAGA and PIO in fa/fa rats subjected
to both prevention and intervention treatments (eg, prevention HOMA-IR: −71
and −72%, respectively), as was hyperglycaemia (both −68%). BF had no ... Cited by 35 - Related articles - All 5 versions
EH Koh, MS Kim, JY Park, HS Kim, JY Youn, … - Diabetes, 2003 - Am Diabetes Assoc Lipid accumulation in nonadipose tissues is closely related to the development
of type 2 diabetes in obese subjects. We examined the potential preventive
effect of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ ... Cited by 104 - Related articles - BL Direct - All 6 versions
[CITATION] High fat-feeding to rats on the interrelationship of body weight, plasma insulin, and fatty …
